These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model. Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304 [TBL] [Abstract][Full Text] [Related]
26. Digoxin bioavailability: formulations and rates of infusions. Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346 [TBL] [Abstract][Full Text] [Related]
27. [Biologic availability of digoxin in soft gelatin capsules and in tablets]. Merotti GC; Ghirardi P; Marzo A; Parenti MA Boll Soc Ital Biol Sper; 1974 Oct; 50(19):1612-4. PubMed ID: 4458749 [No Abstract] [Full Text] [Related]
28. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps. Johnson BF; Smith G; French J Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135 [TBL] [Abstract][Full Text] [Related]
29. Proceedings: Bio availability of digoxin and derivatives. Rietbrock N; Guggenmos J Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R80. PubMed ID: 4276634 [No Abstract] [Full Text] [Related]
30. The relation of bioavailability to the dissolution rate of experimentally produced digoxin tablets. Johnson BF; Greer H; McCrerie JA; Bye C; Fowle AS Postgrad Med J; 1974 Nov; 50 Suppl 6():48-52. PubMed ID: 4617868 [No Abstract] [Full Text] [Related]
31. Variability of steady-state digoxin kinetics during administration of tablets or capsules. Johnson BF; Lindenbaum J; Budnitz E; Marwaha R Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469 [TBL] [Abstract][Full Text] [Related]
32. [Enhanced bioavailability of digoxin from silica matrix formulations (author's transl)]. Flasch H; Asmussen B; Heinz N Arzneimittelforschung; 1978; 28(2):326-30. PubMed ID: 205226 [TBL] [Abstract][Full Text] [Related]
33. The absorption of digoxin tablets. Binnion PF Clin Pharmacol Ther; 1974 Nov; 16(5 Part 1):807-12. PubMed ID: 4426149 [No Abstract] [Full Text] [Related]
34. Bioavailability of drugs: the digoxin dilemma. Greenblatt DJ; Smith TW; Koch-Weser J Clin Pharmacokinet; 1976; 1(1):36-51. PubMed ID: 797491 [TBL] [Abstract][Full Text] [Related]
36. The biological availability of very rapidly dissolving digoxin tablets. Shaw TR; Raymond K; Greenwood H Postgrad Med J; 1974 Nov; 50 Suppl 6():55-9. PubMed ID: 4459890 [No Abstract] [Full Text] [Related]
37. Physical and dissolution characteristics and bio-availability of five brands of digoxin tablets. Fletcher S; Summers RS S Afr Med J; 1980 Apr; 57(14):530-3. PubMed ID: 7368019 [TBL] [Abstract][Full Text] [Related]
38. Greater bioavailability of digoxin solution in capsules. Studies in the postprandial state. Lindenbaum J Clin Pharmacol Ther; 1977 Mar; 21(3):278-82. PubMed ID: 576419 [TBL] [Abstract][Full Text] [Related]
39. [Bioavailability of beta-acetyldigoxin and digoxin (author's transl)]. Flasch H Klin Wochenschr; 1975 Sep; 53(18):873-7. PubMed ID: 1172599 [TBL] [Abstract][Full Text] [Related]
40. Rate of dissolution of digoxin tablets as a predictor of absorption. Johnson BF; Greer H; McCrerie J; Bye C; Fowle A Lancet; 1973 Jun; 1(7818):1473-5. PubMed ID: 4123140 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]